INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![Bladder and Kidneys-GettyImages-1339092350]( "Tailored Approach Supports Bladder Cancer Breakthrough")
Tailored Approach Supports Bladder Cancer BreakthroughDiscover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.
-
![oncology-clinical-GettyImages-2228804507]( "Improving Early Phase Oncology Trial Execution With A Site-First Approach")
Improving Early Phase Oncology Trial Execution With A Site-First ApproachTrials that look good on paper often stall at the site. Learn how involving sites early in study design cuts delays and keeps early-phase cancer studies on track from startup to patients.
-
![GettyImages-1987435635 research, planning]( "Rescuing A Global Program For NDA Success")
Rescuing A Global Program For NDA SuccessExplore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
![business-people-shaking-hands-GettyImages-908944978]( "Establishing Trust With Real People In Clinical Research")
Establishing Trust With Real People In Clinical ResearchGet actionable strategies to enhance engagement, strengthen relationships, and support study success in clinical research through clear communication, transparency, and ethical practices.
-
Restoring The American Biotechnology Edge10/13/2026
Michelle Longmire explores why startup delays, enrollment friction, fragmented systems, and rising costs put trials at a competitive disadvantage.
-
What Drives Attendance And Engagement At Clinical Meetings?5/6/2026
A clear look at what drives attendance and engagement at clinical meetings, and how design decisions shape comprehension, retention, and consistency as programs scale globally over time.
-
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call3/21/2025
Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
Modern Site Operating Models For Complex Portfolios10/31/2026
When injectable and biologic volumes swing and disruption is barely tolerated, can a packaging plant organized by function keep pace? Splitting one site into focus factories suggests another model.
-
Cell & Gene Unscripted: Strategy Solutions9/17/2026
What does it take to deliver complex cell & gene therapies to patients worldwide? Elisa Galvez & Chris Learn explore site readiness & logistics on Cell & Gene Unscripted.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1180547354 clinical trial tablet research]( "Full Service CRO And Regulatory Partner For Biologics")
Advancing biologics from start to finish is highly complex and full of challenges, requiring scientific strategies and implementation.
-
![GettyImages-1083316464_eye]( "Your Top Partner For Ophthalmic Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
![GettyImages-1465572768 clinical site solution]( "A Definitive Guide To The Site Enablement Maturity Assessment")
Clinical research sites play a crucial role in data collection, patient interactions, and protocol procedures. Utilize this methodology for uncovering site enablement capability maturity.
-
![GettyImages-691189734-pill-analysis-microscope-gloved-hand]( "Human ADME Studies: Human Metabolism Data For Regulatory Submission")
Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.
-
![GettyImages-1206874823_flow cytometry_lab]( "Flow Cytometry And PBMC Isolation — Powerful Tools For Your Clinical Trials")
Did you know? Altasciences’ clinical facilities are integrated with state-of-the-art flow cytometry laboratories. With our deep expertise in regulated cellular analysis, our team ensures that every step — from sample collection and processing to transport and analysis — is optimized for precision and speed.
